Fintel reports that on September 29, 2025, Canaccord Genuity maintained coverage of Tandem Diabetes Care (NasdaqGM:TNDM) with ...

Shares of diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) jumped 5% in the morning session after the company announced the publication of a study showing its automated insulin delivery ...

Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of ...

In the last three months, 12 analysts have published ratings on Tandem Diabetes Care (NASDAQ:TNDM), offering a diverse range of perspectives from bullish to bearish. The following table provides a ...

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is one of the stocks Jim Cramer shared insights on. Inquiring about the stock during the lightning round, a caller expressed that their son and grandson use ...

All right. Good morning, everyone. Thanks for joining us for this fireside chat with Tandem Diabetes Care. My name is [ Jacob Dodd ], and I work with Patrick Wood on the U.S. med tech team here. And I ...

NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc.

The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Tandem Diabetes Care, Inc. (“Tandem” or “the Company”) (NASDAQ: ...

WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from ...